A detailed history of Balboa Wealth Partners transactions in Amgen Inc stock. As of the latest transaction made, Balboa Wealth Partners holds 1,797 shares of AMGN stock, worth $464,686. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,797
Previous 1,194 50.5%
Holding current value
$464,686
Previous $373,000 55.23%
% of portfolio
0.15%
Previous 0.1%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$309.38 - $337.38 $186,556 - $203,440
603 Added 50.5%
1,797 $579,000
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $31,004 - $37,678
118 Added 10.97%
1,194 $373,000
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $68,830 - $83,087
-256 Reduced 19.22%
1,076 $305,000
Q4 2023

Feb 09, 2024

BUY
$255.7 - $288.46 $98,700 - $111,345
386 Added 40.8%
1,332 $383,000
Q3 2023

Oct 23, 2023

BUY
$218.65 - $271.46 $206,842 - $256,801
946 New
946 $254,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $278,729 - $354,159
1,217 New
1,217 $319,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $138B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Balboa Wealth Partners Portfolio

Follow Balboa Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balboa Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Balboa Wealth Partners with notifications on news.